NCT05013905 - A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

September 23, 2022

Study Completion Date

May 27, 2025

Conditions

Crohn Disease

Interventions

DRUG

PRA023 IV

PRA023 administered at timepoints as directed by the protocol

DEVICE

Companion diagnostic (CDx)

CDx+ or CDx-

Trial Locations (37)

2146

Prometheus Biosciences Selected Site, Bankstown

3000

Prometheus Biosciences Selected Site, Leuven

4000

Prometheus Biosciences Selected Site, Liège

4102

Prometheus Biosciences Selected Site, Woolloongabba

5000

Prometheus Biosciences Selected Site, Adelaide

10065

Prometheus Biosciences Selected Site, New York

42270

Prometheus Biosciences Selected Site, Saint-Priest-en-Jarez

48047

Prometheus Biosciences Selected Site, Chesterfield

48197

Prometheus Biosciences Selected Site, Ypsilanti

54511

Prometheus Biosciences Selected Site, Vandœuvre-lès-Nancy

63141

Prometheus Biosciences Selected Site, St Louis

64098

Prometheus Biosciences Selected Site, Liberty

75044

Prometheus Biosciences Selected Site, Garland

75702

Prometheus Biosciences Selected Site, Tyler

78229

Prometheus Biosciences Selected Site, San Antonio

Prometheus Biosciences Selected Site, Southlake

79410

Prometheus Biosciences Selected Site, Lubbock

79424

Prometheus Biosciences Selected Site, Lubbock

90045

Prometheus Biosciences Selected Site, Los Angeles

90048

Prometheus Biosciences Selected Site, Los Angeles

92110

Prometheus Biosciences Selected Site, Clichy

98004

Prometheus Biosciences Selected Site, Bellevue

98405

Prometheus Biosciences Selected Site, Tacoma

03756

Prometheus Biosciences Selected Site, Lebanon

N6A 5W9

Prometheus Biosciences Selected Site, London

Unknown

Prometheus Biosciences Selected Site, Brno

Prometheus Biosciences Selected Site, Tbilisi

274 01

Prometheus Biosciences Selected Site, Slaný

06202

Prometheus Biosciences Selected Site, Nice

31-501

Prometheus Biosciences Selected Center, Krakow

35-326

Prometheus Biosciences Selected Site, Rzeszów

81-756

Prometheus Biosciences Selected Site, Sopot

87-100

Prometheus Biosciences Selected Site, Torun

00-635

Prometheus Biosciences Selected Center, Warsaw

03-580

Prometheus Biosciences Selected Site, Warsaw

52-416

Prometheus Biosciences Selected Center, Warsaw

Prometheus Biosciences Selected Site, Wroclaw

All Listed Sponsors

lead

Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY